Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11771653 Lipid nanoparticles for delivering mRNA vaccines

Patent 11771653 was granted and assigned to Sanofi on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Sanofi
Sanofi
Date Filed
June 30, 2022
Date of Patent
October 3, 2023
Patent Applicant
Sanofi
Sanofi
Patent Application Number
17810064
Patent Citations
‌
US Patent 9006417 Non-liposomal systems for nucleic acid delivery
‌
US Patent 9364435 Lipid formulations for nucleic acid delivery
‌
US Patent 9404127 Non-liposomal systems for nucleic acid delivery
‌
US Patent 7803397 Polyethyleneglycol-modified lipid compounds and uses thereof
‌
US Patent 8058069 Lipid formulations for nucleic acid delivery
‌
US Patent 8492359 Lipid formulations for nucleic acid delivery
‌
US Patent 8822668 Lipid formulations for nucleic acid delivery
‌
US Patent 8936942 Polyethyleneglycol-modified lipid compounds and uses thereof
‌
US Patent 10137087 Lipid-derived neutral nanoparticles
‌
US Patent 10138213 Stereochemically enriched compositions for delivery of nucleic acids
•••
Patent Inventor Names
Sudha Chivukula
Shrirang Karve
Asad Khanmohammed
Anusha Dias
Priyal Patel
Danilo Casimiro
Timothy Plitnik
Hardip Rajeshbhai Gopani
Kirill Kalnin
Timothy Tibbitts
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11771653
Patent Primary Examiner
‌
Isaac Shomer
CPC Code
‌
A61K 9/1272
‌
A61P 31/16

Find more entities like US Patent 11771653 Lipid nanoparticles for delivering mRNA vaccines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.